<DOC>
	<DOCNO>NCT00262405</DOCNO>
	<brief_summary>Open label trial zileuton compare azathioprine/prednisone patient idiopathic pulmonary fibrosis . Study subject undergo detailed clinical , radiographic , physiologic assessment baseline . Subjects monitor treatment three month change symptom physiology . Subjects randomize six month treatment zileuton azathioprine/prednisone . The primary endpoint trial change LTB4 level bronchoalveolar lavage fluid follow six month treatment . Secondary endpoint progression free survival , change dyspnea , change quality life , change physiology .</brief_summary>
	<brief_title>Zileuton Treatment Idiopathic Pulmonary Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<mesh_term>Zileuton</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<mesh_term>Hydroxyurea</mesh_term>
	<criteria>Diagnosis idiopathic pulmonary fibrosis Taking &lt; 15 mg prednisone least 30 day prior screen Age 3580 , inclusive Able understand write informed consent comply study protocol Significant environmental exposure Diagnosis collagen vascular disease Evidence active infection Clinically significant cardiac disease Myocardial infarction , coronary artery bypass angioplasty within 6mo Unstable angina pectoris Congestive heart failure require hospitalization within 6 month Uncontrolled arrhythmia Poorly control severe diabetes mellitus Pregnancy lactation Women childbearing potential use medically approve mean contraception ( i.e . oral contraceptive , intrauterine device , diaphragm , Norplant ) Current enrollment another experimental protocol Physiologic Criteria : FEV1/FVC &lt; 0.60 Laboratory Criteria : Total bilirubin &gt; 1.5 X upper limit normal AST ALT &gt; 3X upper limit normal Alkaline phosphatase &gt; 3X upper limit normal White blood cell count &lt; 2,500/mm3 Hematocrit &lt; 30 % Platelets &lt; 100,000/mm3 Prothrombin time INR &gt; 1.5</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>